[Immunoscintigraphy of oncologic tumors].
The paper describes the foundations of immunoscintigraphy and its value for initial and follow-up investigation of ovarian carcinoma in comparison with established methods and the "second look". It appeared, that immunoscintigraphy is superior to computed tomography especially in case of large and diffuse processes as peritoneal carcinosis and allows a classification of morphologically hardly accessible tissue structures into benign (scars, strictures etc.) and malign structures (recidives, metastases, peritoneal carcinosis). Therefore in case of clinically suspected recidives immunoscintigraphy is recommended in case of a negative CT-investigation.
Barzen
G
G
D000368:Aged; D000911:Antibodies, Monoclonal; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000276:immunology*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging* / Q000276:immunology; D011877:Radionuclide Imaging
D000911:Antibodies, Monoclonal; D015295:Antigens, Tumor-Associated, Carbohydrate; D007457:Iodine Radioisotopes
Immunszintigraphie bei onkologischen Tumoren.